Nacresertib
Sponsors
AbbVie
Conditions
Healthy VolunteerHealthy Volunteers
Phase 1
A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants
CompletedNCT07566130
Start: 2025-04-18End: 2026-05-07Updated: 2026-06-04
A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants
CompletedNCT07600762
Start: 2026-04-21End: 2026-06-17Updated: 2026-07-20
A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
Active, not recruitingNCT07649954
Start: 2026-06-23End: 2026-10-01Updated: 2026-09-18